Healthcare provider profile · identity verified

Aaron Patrick Hanson, DO

Family Practice · SALEM, OR · NPI 1528087400

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	593	171
Lisinopril	Lisinopril	506	145
Losartan Potassium	Losartan Potassium	309	88
Amlodipine Besylate	Amlodipine Besylate	305	95
Levothyroxine Sodium	Levothyroxine Sodium	275	77
Gabapentin	Gabapentin	260	79
Simvastatin	Simvastatin	257	74
Pantoprazole Sodium	Pantoprazole Sodium	242	77
Metformin Hcl	Metformin Hcl	236	69
Oxycodone Hcl	Oxycodone Hcl	223	38
Trazodone Hcl	Trazodone Hcl	221	76
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	208	43
Metoprolol Tartrate	Metoprolol Tartrate	188	53
Rosuvastatin Calcium	Rosuvastatin Calcium	187	53
Albuterol Sulfate Hfa	Albuterol Sulfate	178	73
Atenolol	Atenolol	169	43
Pradaxa	Dabigatran Etexilate Mesylate	167	41
Potassium Chloride	Potassium Chloride	164	48
Tamsulosin Hcl	Tamsulosin Hcl	155	54
Glipizide	Glipizide	152	52
Hydrochlorothiazide	Hydrochlorothiazide	146	51
Duloxetine Hcl	Duloxetine Hcl	130	35
Furosemide	Furosemide	129	42
Metformin Hcl Er	Metformin Hcl	127	38
Allopurinol	Allopurinol	125	32
Humulin N	Insulin Nph Human Isophane	122	34
Fluoxetine Hcl	Fluoxetine Hcl	119	30
Omeprazole	Omeprazole	107	27
Tramadol Hcl	Tramadol Hcl	102	22
Wixela Inhub	Fluticasone Propion/Salmeterol	88	23
Metoprolol Succinate	Metoprolol Succinate	79	30
Naproxen	Naproxen	79	21
Sertraline Hcl	Sertraline Hcl	78	27
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	78	24
Bupropion Xl	Bupropion Hcl	77	27
Carvedilol	Carvedilol	77	24
Warfarin Sodium	Warfarin Sodium	77	23
Alvesco	Ciclesonide	75	25
Pravastatin Sodium	Pravastatin Sodium	74	23
Pregabalin	Pregabalin	72	25
Alendronate Sodium	Alendronate Sodium	69	22
Buspirone Hcl	Buspirone Hcl	65	15
Escitalopram Oxalate	Escitalopram Oxalate	65	15
Meloxicam	Meloxicam	65	23
Ondansetron Odt	Ondansetron	64	17
Mirtazapine	Mirtazapine	63	25
Clopidogrel	Clopidogrel Bisulfate	62	17
Spiriva Respimat	Tiotropium Bromide	62	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	13
Prednisone	Prednisone	61	32
Jardiance	Empagliflozin	56	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	21
Donepezil Hcl	Donepezil Hcl	55	14
Shingrix	Varicella-Zoster Ge/As01b/Pf	55	51
Isosorbide Mononitrate Er	Isosorbide Mononitrate	54	12
Triamcinolone Acetonide	Triamcinolone Acetonide	51	26
Spironolactone	Spironolactone	48	19
Montelukast Sodium	Montelukast Sodium	47	15
Doxycycline Monohydrate	Doxycycline Monohydrate	46	25
Hydralazine Hcl	Hydralazine Hcl	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Finasteride	Finasteride	42	11
Bisoprolol Fumarate	Bisoprolol Fumarate	41	11
Fluticasone Propionate	Fluticasone Propionate	41	17
Terazosin Hcl	Terazosin Hcl	41	13
Morphine Sulfate Er	Morphine Sulfate	39	suppressed
Propranolol Hcl	Propranolol Hcl	39	13
Famotidine	Famotidine	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	32
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	36	suppressed
Chlorthalidone	Chlorthalidone	35	13
Humulin R	Insulin Regular, Human	34	14
Paxlovid	Nirmatrelvir/Ritonavir	34	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	12
Humulin N Kwikpen	Insulin Nph Human Isophane	33	11
Lovastatin	Lovastatin	33	suppressed
Clonazepam	Clonazepam	31	suppressed
Nitroglycerin	Nitroglycerin	31	19
Eliquis	Apixaban	30	suppressed
Hydrocortisone	Hydrocortisone	29	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	11
Ozempic	Semaglutide	28	suppressed
Acyclovir	Acyclovir	26	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Cephalexin	Cephalexin	25	18
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Estradiol	Estradiol	25	12
Topiramate	Topiramate	25	13
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	24	24
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Amoxicillin	Amoxicillin	22	21
Azithromycin	Azithromycin	22	11
Doxepin Hcl	Doxepin Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Cefadroxil	Cefadroxil	20	20
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	20	19
Lactulose	Lactulose	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Latanoprost	Latanoprost	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Cartia Xt	Diltiazem Hcl	18	suppressed
Trospium Chloride	Trospium Chloride	18	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Safetyglide Insulin Syringe	Syringe,needle,insuln,sf,0.3ml	15	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	15	suppressed
Cefuroxime	Cefuroxime Axetil	14	12
Fluconazole	Fluconazole	14	12
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	13	suppressed
Baclofen	Baclofen	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Codeine Sulfate	Codeine Sulfate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error